SHANGHAI, China I September 2, 2024 I Shanghai Henlius Biotech, Inc. (2696.HK) announced the investigational new drug (IND) application for clinical trial of HLX17, a pembrolizumab biosimilar ...

Treatment with lenvatinib (Lenvima) and pembrolizumab (Keytruda) led to significantly longer rates of progression-free survival (PFS) and overall survival (OS) in the phase 3 CLEAR study (NCT02811861) ...

Patients who discontinued prior anti-PD-(L)1 therapy due to an anti-PD-(L)1-related toxicity (applicable to the KFA115 in combination with pembrolizumab treatment arms). - Patients with symptomatic ...

The invention of a tool capable of unlocking previously impossible organic chemical reactions has opened ... of derivatives to fine-tune a molecule's structure and performance, so we teamed ...

Minimum investments vary for each fund, the structure of private equity funds historically follows a framework that includes classes of fund partners, management fees, investment horizons ...

An alternative to this is chemical recycling, which avoids loss of quality. This method involves breaking down long-chain plastic molecules (polymers) into their fundamental building blocks ...

Pembrolizumab biosimilar is under clinical development by Biocad and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData, Phase I drugs for Non-Small Cell Lung Cancer have an ...

Panelists discuss how the combination therapy of cretostimogene plus pembrolizumab offers a promising new approach for managing BCG-unresponsive non-muscle-invasive bladder cancer, highlighting its ...

Physical Chemistry Chemical Physics (Phys. Chem. Chem. Phys. or PCCP) is a peer-reviewed scientific journal publishing original (primary) research and review articles on any aspect of physical ...

Pembrolizumab and other immunotherapies have become central in treating metastatic colon cancer, particularly effective in patients with mismatch repair deficiencies. We report a case involving a man ...